Globus Medical Inc. advanced stock charts by Barron's. View GMED historical stock data and compare to other stocks, and exchanges.

Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of ...

Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...

Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

BTIG lowered the firm’s price target on Globus Medical (GMED) to $88 from $94 and keeps a Buy rating on the shares as part of a broader ...

These are also areas where the burden of disease is high and access to medical care can be low. Data from the Australian Bureau of Statistics shows that while life expectancy has been improving ...

Getting life insurance typically requires a medical exam to give your provider a clearer picture of your health status. But there are policies available that don't require an examination ...

Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...

Commissions do not affect our editors' opinions or evaluations. Major medical insurance is comprehensive health insurance that covers medical services, hospitalizations, doctor visits ...

On Thursday, JMP analysts maintained their Market Perform rating for Globus Medical (NYSE:GMED) stock, currently trading at $74.28 with a market capitalization of $10.22 billion. The analysts' stance ...